Platelet Amyloid Precursor Protein Abnormalities in Mild Cognitive Impairment Predict Conversion to Dementia of Alzheimer Type
Authors:
- Francesca ColciaghiFCFrancesca Colciaghi
- Carlo CaltagironeCCCarlo Caltagirone
- Luca RozziniLRLuca Rozzini
- Laura BroglioLBLaura Broglio
- Flaminio CattabeniFCFlaminio Cattabeni
- Monica Di LucaMLMonica Di Luca
- Alessandro PadovaniAPAlessandro Padovani
Open Access
- 1 December 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 60 (12) , 1740-1744
Abstract
ASLIGHT impairment in cognitive functions, notably memory, with otherwise normal performances has been designated as mild cognitive impairment (MCI), and has become a topic of considerable research in the past few years.1-3Keywords
This publication has 21 references indexed in Scilit:
- Cerebrospinal Fluid Tau and β-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive ImpairmentArchives of Neurology, 2002
- CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjectsNeurology, 2002
- Of MCI and dementia: Improving diagnosis and treatmentNeurology, 2001
- Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]Neurology, 2001
- Mild Cognitive Impairment Represents Early-Stage Alzheimer DiseaseArchives of Neurology, 2001
- Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory LossArchives of Neurology, 2001
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- Mild cognitive impairment: conceptual basis and current nosological statusThe Lancet, 2000
- Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer DiseaseArchives of Neurology, 2000
- Altered Amyloid Protein Processing in Platelets of Patients With Alzheimer DiseaseArchives of Neurology, 1997